Showing 1,161 - 1,180 results of 2,687 for search '"chemotherapy"', query time: 0.06s Refine Results
  1. 1161

    Case Report: Robot-assisted laparoscopic bladder diverticulectomy: a case series and initial experience by Guangju Ge, Haihong Wang, Qiming Zheng, Shuai Zhang, Huan Wang, Liang Ma

    Published 2025-01-01
    “…To minimize the risk of intraoperative tumor spread, we implemented enhanced surgical techniques. Systemic chemotherapy and adjuvant intravesical chemotherapy were recommended to reduce the risk of tumor recurrence and metastasis.ResultsPostoperative pathology confirmed papillary urothelial carcinoma in all three cases. …”
    Get full text
    Article
  2. 1162

    Prolonged Myelosuppression due to Progressive Bone Marrow Fibrosis in a Patient with Acute Promyelocytic Leukemia by Yuta Inagawa, Yukiko Komeno, Satoshi Saito, Yuji Maenohara, Tetsuro Yamagishi, Hiroyuki Kawashima, Taku Saito, Keiko Abe, Kuniko Iihara, Yasumasa Hatada, Tomiko Ryu

    Published 2019-01-01
    “…A 34-year-old woman was diagnosed with acute promyelocytic leukemia. Chemotherapy was administered following the JALSG APL204 protocol. …”
    Get full text
    Article
  3. 1163

    Diagnosis and treatment of thyroblastoma: a case report and review of literature by Xiting Chen, Xiting Chen, Lijuan Xiong, Lijuan Xiong, Hongling Liu, Haoqiang Wang, Donghai Cheng, Wei Wang, Wenyuan He, Bo Xie, Juan Zhou

    Published 2025-02-01
    “…Despite local thyroid tumor resection, the disease continued to progress rapidly. However, chemotherapy with BEP led to a reduction in the tumor. …”
    Get full text
    Article
  4. 1164

    Risk Factors of Noncompliance to Preventive Mass Drug Administration for Eliminating Lymphatic Filariasis: A Case-Control Study in Jawi District, Northwest Ethiopia by Fetene Mihretu, Gebeyehu Tsega, Melesse Belayneh, Mesafint Molla Adane

    Published 2022-01-01
    “…All individuals who are permanently living in the study area and registered on the annual chemotherapy registration book since 2015 were included in this study. …”
    Get full text
    Article
  5. 1165

    Diagnostic performance of the DISQVER metagenomic sequencing tool for the identification of pathogens in febrile neutropenic patients: the ADNEMIA trial by Geneviève Héry-Arnaud, Christophe Burucoa, Marie Kempf, David Boutoille, Yohann Foucher, Philippe Lanotte, Maxime Pichon, Stéphane Corvec, Cécile Le Brun, Helene Pailhories

    Published 2025-01-01
    “…Introduction While intensive protocols in onco-haematology have improved survival rates for patients with haematological malignancies, they have also resulted in an increased incidence of infection associated with therapy-induced immunosuppression (including chemotherapy-induced febrile neutropenia; FN). The occurrence of FN, associated with high morbidity and mortality, necessitates broad-spectrum antibiotic therapy, occasioning delayed chemotherapy and resulting in a loss of opportunity for the patient. …”
    Get full text
    Article
  6. 1166

    Metering effects in population systems by Erika T. Camacho, Christopher M. Kribs-Zaleta, Stephen Wirkus

    Published 2013-07-01
    “…These effects are illustrated by applications tomodels for chemotherapy dosing and for eating disorders in a school setting.…”
    Get full text
    Article
  7. 1167

    Primary Lymphoma of the Liver: A Case Report and Review by Franzjosef Schweiger, Rowen Shinder, Sheldon Rubin

    Published 2000-01-01
    “…The response to treatment varies, but surgical resection and/or chemotherapy can result in prolonged remissions. The literature on this topic is briefly reviewed.…”
    Get full text
    Article
  8. 1168

    Hemophagocytic lymphohistiocytosis secondary to refractory acute myeloid leukemia resolved after second line treatment with azacitidine plus venetoclax by Claudio Fozza

    Published 2024-01-01
    “…Secondary HLH typically occurs in conjunction with severe infections, malignancies or autoimmune disorders and intensive chemotherapy, potentially complicating treatment of acute myeloid leukemia (AML) in around 10% of cases. …”
    Get full text
    Article
  9. 1169

    Optimal Treatment for Intermediate- and High-Risk, Nonmuscle-Invasive Bladder Cancer by A.P.M. van der Meijden

    Published 2006-01-01
    “…The prognosis is determined by the likelihood of recurrence(30-70%) and/or progression to muscle invasive bladder cancer(1-15%).Trans urethral resection of bladder tumors remains the initial therapy but adjuvant intravesical instillations are necessary.All patients benefit from a single immediate post operative instillation with a chemotherapeutic agent and for low risk tumors this is the optimal therapy.Patients with intermediate and high risk tumors need more intravesical chemo-or immunotherapy. Chemotherapy reduces recurrences but not progression. …”
    Get full text
    Article
  10. 1170

    Interactions between the tumor microbiota and breast cancer by Hua Guo

    Published 2025-01-01
    “…Gut microbes and their metabolites influence the development of breast cancer by regulating the tumor immune response, estrogen metabolism, chemotherapy, and immunotherapy effects. It was previously thought that there were no microorganisms in breast tissue, but it is now thought that there are microorganisms in breast cancer that can affect the outcome of the disease. …”
    Get full text
    Article
  11. 1171
  12. 1172

    Jejunal Perforation: A Rare Presentation of Burkitt’s Lymphoma—Successful Management by Samir Ranjan Nayak, Ganni Bhaskara Rao, Subramanya Sarma Yerraguntla, Sisir Bodepudi

    Published 2014-01-01
    “…We present an interesting case of jejunal perforation as a first manifestation of Burkitt’s lymphoma which was successfully managed with surgical resection, high dose chemotherapy, and good supportive care.…”
    Get full text
    Article
  13. 1173
  14. 1174

    Finite-difference and pseudo-spectral methodsfor the numerical simulations of in vitro human tumor cellpopulation kinetics by Z. Jackiewicz, B. Zubik-Kowal, B. Basse

    Published 2009-05-01
    “…Pseudo-spectral approximations areconstructed for the model equations describing the populationkinetics of human tumor cells in vitro and their responses toradiotherapy or chemotherapy. These approximations are moreefficient than finite-difference approximations. …”
    Get full text
    Article
  15. 1175

    Recurrent Cervical Cancer Treated Successfully with Single-Agent PARP-Inhibitor, Olaparib by Maya Gross, Ryan J. Spencer

    Published 2022-01-01
    “…Current treatment options are limited; standards of care such as palliative chemotherapy and surgical resection often provide a small survival advantage. …”
    Get full text
    Article
  16. 1176

    Gene Expression in Oligodendroglial Tumors by Elisabeth J. Shaw, Brian Haylock, David Husband, Daniel du Plessis, D. Ross Sibson, Peter C. Warnke, Carol Walker

    Published 2010-01-01
    “…Background: Oligodendroglial tumors with 1p/19q loss are more likely to be chemosensitive and have longer survival than those with intact 1p/19q, but not all respond to chemotherapy, warranting investigation of the biological basis of chemosensitivity.…”
    Get full text
    Article
  17. 1177

    Primary sclerosing encapsulating peritonitis by Swati Mishra, Kuldeep Chaudhary, Swati Tyagi, Pratibha Mishra, Vatsala Misra

    Published 2023-01-01
    “…It can be primary (idiopathic) or secondary (chemotherapy, beta-blockers, peritoneal dialysis, shunts, tuberculosis, systemic lupus erythematosus, etc.). …”
    Get full text
    Article
  18. 1178

    A Fatal Case of Primary Basaloid Squamous Cell Carcinoma in the Intrahepatic Bile Ducts by Johan Kirkegaard, Mie Grunnet, Jane Preuss Hasselby

    Published 2014-01-01
    “…We describe a case of a 67-year-old man, who underwent chemotherapy and surgery for a right-sided liver tumor with an unusual presentation of metastasis to a lymph node in the left armpit. …”
    Get full text
    Article
  19. 1179

    Oxaliplatin-Induced Pulmonary Toxicity in Gastrointestinal Malignancies: Two Case Reports and Review of the Literature by Mor Moskovitz, Mira Wollner, Nissim Haim

    Published 2015-01-01
    “…Oxaliplatin is a common chemotherapy drug, used mainly for colon and gastric cancer. …”
    Get full text
    Article
  20. 1180

    A Rare Case of Renal Recovery in a Young Patient with Multiple Myeloma by Hasan J. Salameh, Adeel Ahmad, Tina Kochar

    Published 2013-01-01
    “…We describe an atypical presentation of MM in a young patient who presented with severe renal insufficiency requiring renal replacement therapy and achieved complete renal recovery with chemotherapy.…”
    Get full text
    Article